Browsing by Author Bethel, M. Angelyn

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2010Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular EventsFulcher, Greg; Belenkov, Yuri; Bethel, M. Angelyn; Boolell, Mitradev; Buckley, Brendan M.; Buse, John B.; Chacra, Antonio R.; et al, various; Haffner, Steven; Holman, Rury R.; Holzhauer, Björn; Hua, Tsushung A.; McMurray, John J.V.; Northern Clinical School: MedicineEffect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events, New England Journal of Medicine, vol.362, 16,pp 1463-1476
2010Effect of Valsartan on the Incidence of Diabetes and Cardiovascular EventsFulcher, Greg; Belenkov, Yuri; Bethel, M. Angelyn; Boolell, Mitradev; Buckley, Brendan M.; Buse, John B.; Chacra, Antonio R.; et al, various; Haffner, Steven; Holman, Rury R.; Holzhauer, Björn; Hua, Tsushung A.; McMurray, John J.V.; Northern Clinical School: MedicineEffect of Valsartan on the Incidence of Diabetes and Cardiovascular Events, New England Journal of Medicine, vol.362, 16,pp 1477-1490
2013A Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular RiskFulcher, Greg; Bethel, M. Angelyn; Califf, Robert M.; Chacra, Antonio R.; Deedwania, Prakash; et al, Various; Holman, Rury; Jenssen, Trond; Kahn, Steven; Levitt, Naomi; McMurray, John; Raptis, Sotirios; Northern Clinical School: MedicineA Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular Risk, The American Journal of Cardiology, vol.112, 2, 2013,pp 231-237